Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference

Oleg Otlivanchik1, Nicole M Sanders2, Ambrose Dunn-Meynell3

  • 1Graduate School of Biomedical Sciences, Rutgers University, Newark, New Jersey; Department of Neurology, New Jersey Medical School, Rutgers University, Newark, New Jersey;

Insights

Recurrent hypoglycemia blunts behavioral responses, a key aspect of hypoglycemia unawareness. Orexin neurons play a role in these responses, offering insights into brain mechanisms.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Behavioral Science

Background:

  • Neural control of glucoregulation is increasingly understood.
  • Brain mechanisms of behavioral responses to hypoglycemia remain poorly understood.
  • Hypoglycemia unawareness is a significant clinical concern.

Purpose of the Study:

  • To investigate central control mechanisms of hypoglycemia unawareness.
  • To evaluate the effect of recurrent hypoglycemia on behavioral responses.
  • To establish a behavioral model for studying hypoglycemia unawareness.

Main Methods:

  • Evaluated feeding response to recurrent insulin-induced hypoglycemia (IIH) in rats.
  • Developed a conditioned place preference (CPP) model to assess hypoglycemia-induced behavioral arousal.
  • Administered orexin receptor-1 antagonist (SB-334867A) and sertraline to assess their effects.

Main Results:

  • Recurrent IIH did not impair feeding response.
  • Hypoglycemia blunted previously acquired CPP, an effect prevented by recurrent hypoglycemia.
  • Orexin receptor-1 antagonist blocked hypoglycemia-induced CPP blunting.
  • Recurrent hypoglycemia decreased preproorexin expression in the perifornical hypothalamus.
  • Sertraline did not prevent the blunting of CPP.

Conclusions:

  • This study presents the first behavioral model of hypoglycemia unawareness.
  • Orexin neurons are implicated in mediating behavioral responses to hypoglycemia.
  • Recurrent hypoglycemia alters behavioral responses, potentially contributing to unawareness.

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K